SCHEMBL1675128

SCHEMBL1675128

CCNC(=O)c1ccc(-c2ccc3ncnc(NCc4nccs4)c3c2)o1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 17/20 0.61
CLK1 P49759 9/20 0.61
DYRK1A Q13627 9/20 0.61
CLK2 P49760 7/20 0.61
DYRK1B Q9Y463 7/20 0.61
CLK3 P49761 2/20 0.54
LMNA P02545 4/20 0.44
ALDH1A1 P00352 3/20 0.44
CYP1A2 P05177 3/20 0.44
CYP3A4 P08684 3/20 0.44
CYP2D6 P10635 3/20 0.44
MAPK1 P28482 3/20 0.44
CYP2C19 P33261 3/20 0.44
HSD17B10 Q99714 2/20 0.44
APEX1 P27695 2/20 0.44
CASP7 P55210 2/20 0.44
USP2 O75604 1/20 0.44
CYP2C9 P11712 2/20 0.44
TSHR P16473 2/20 0.44
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1675219 0.89 CLK4 (0.57) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675152 0.88 CLK4 (0.75) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675287 0.83 CLK4 (0.79) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675232 0.82 CLK4 (0.66) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675203 0.81 CLK4 (0.73) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675108 0.80 CLK4 (0.62) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675107 0.78 CLK4 (0.70) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675111 0.77 CLK4 (0.57) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675356 0.76 CLK4 (0.49) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675337 0.75 CLK4 (1.00) CLK4CLK1DYRK1ACLK2DYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed